Gurans Life Insurance Company Ltd. (GLICL)
Life Insurance · Rs. 344.00 -7.00 (-1.99%) as of May 8, 2023
Price — last 6 months
Full chart →Open
351.10
High / Low
353.90 / 340.10
Prev. close
351.00
Volume
26,209
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—
MASTER score
Mechanical 0–100 technical ranking. Methodology →
Promoter holding—
Public holding—
Stock performance
1-week change
-4.44%
1-month change
-7.03%
3-month change
-15.29%
6-month change
-13.66%
YTD change
-13.66%
1-year change
-15.42%
1-month high
390.00
1-month low
340.10
From 52-week high
—
From 52-week low
—
180-day avg price
372.41
360-day avg price
372.41
Avg volume (1w)
9,742
Avg volume (1m)
10,627
Avg volume (6m)
20,529
Avg volume (12m)
21,941
Daily volatility (1m)
1.96%
Beta vs NEPSE (1y)
—
Valuation
EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—
P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →
Key indicators vs Life Insurance
EPS (Rs.)
N/A
min —avg —max —
—
P/E
N/A
min —avg —max —
—
P/B
N/A
min —avg —max —
—
Networth / Share (Rs.)
N/A
min —avg —max —
—
ROE (%)
N/A
min —avg —max —
—
Technical indicators
| RSI (14) | 34.83 | Neutral |
| MACD | -4.98 | Bearish |
| EMA 5 | 353.18 | Bearish |
| EMA 20 | 362.17 | Bearish |
| EMA 180 | 434.61 | Bearish |
| SMA 50 | 366.13 | Bearish |
| SMA 200 | 447.86 | Bearish |
Pivot levels (classic)
S3
324.30S2
332.20S1
338.10PP
346.00R1
351.90R2
359.80R3
365.70Key financials — last 8 quarters
worsebetter vs same quarter last yearamounts in Rs · per-share in RsNo filed statements found.
More Life Insurance stocks
GLICL — frequently asked questions
What is Gurans Life Insurance Company Ltd.'s share price?
Rs. 344.00 as of May 8, 2023, the latest NEPSE trading session (-1.99% on the day).
What dividend did GLICL pay?
No dividend on record for the most recent fiscal year in our data.
Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.